Merz Aesthetics
The delivery date is confirmed based on stock and suitable shipping.
For delivery within the Netherlands. Orders after 16:00 are processed on the next working day. We confirm delivery dates separately for other countries.Need help with your first order? Use the product enquiry below. Include the number of packs and delivery country. VAT and available shipping costs are shown before payment.
Review the product information first. Create and activate your professional account to see business pricing, volume tiers and current availability. You will then return to this product.
Merz CaHA filler without lidocaine. Composition and official IFU.
RADIESSE® 1.5 ml without lidocaine is an injectable calcium hydroxylapatite (CaHA) implant from Merz Aesthetics in a gel carrier. This version contains no added lidocaine. The detailed information below follows the Dutch IFU; the current IFU supplied with the product and assessment by an authorised healthcare professional remain decisive.
The Dutch instructions for use describe deep dermal and subdermal augmentation of soft tissue. They mention treatment of nasolabial folds, augmentation of the cheeks, correction of volume loss on the back of the hand and restoration/correction of facial volume loss (lipoatrophy) in people with HIV. The exact product choice should depend on the indication, anatomy, patient factors and the full IFU. This list is not advice to treat every area in every patient.
CaHA stands for calcium hydroxylapatite. The gel carrier initially contributes to volume; the CaHA microspheres also support a gradual tissue response. That is a different action profile from an HA filler, and the products are not simply interchangeable. RADIESSE® cannot be dissolved with hyaluronidase in the way an HA filler can; the product-specific approach to a complication belongs with a licensed practitioner and the official information.
The variant without lidocaine differs from RADIESSE® + Lidocaine. Check the full product name before ordering and on receipt. Consult the Dutch IFU for contraindications and warnings; according to the product documentation, the glabella and superficial placement among others require special attention. Only licensed and appropriately trained medical staff should assess the indication and product suitability.
A multicentre, prospective, randomised split-face study compared CaHA (RADIESSE®) with non-animal stabilised hyaluronic acid in nasolabial folds. Sixty patients were included and outcomes were followed for up to 12 months. The publication reported that 79% of CaHA-treated folds were still rated as improved or better at 12 months, compared with 43% for the HA comparator. This is one older study for a defined area and study design; the outcome does not predict an individual result and must not be extended to all indications or current variants. Consult the article for methods and limitations.
Current product documentation may state CE marking and related product documentation; always check the documents for the batch actually supplied. The Dutch Merz IFU describes CE marking under the European MDR and mentions an implant card and lot/traceability labels. The supplied batch can be traced through its lot number. On receipt, check the product name, variant without lidocaine, contents, CE marking, lot/batch code, expiry date, seal and accompanying documentation.
It is a CaHA implant in a gel carrier. It differs in composition and behaviour from a hyaluronic acid filler.
The IFU mentions nasolabial folds, cheeks, the back of the hand and restoration of facial volume loss (lipoatrophy) in people with HIV. Always consult the current Dutch IFU for the precise indications and conditions.
No. This product is the 1.5 ml variant without added lidocaine. RADIESSE® + Lidocaine is a separate version.
The manufacturer's IFU consulted describes one pre-filled 1.5 ml syringe, instructions for use, traceability labels and two sterile needles. Always check the box actually supplied.
The product documentation of the batch actually supplied states the applicable CE marking and related documents; check these details on receipt. The Dutch IFU describes CE marking and lot traceability; check the details on the supplied packaging and implant card.
The Dutch IFU consulted states 15–25 °C, dry and away from sunlight. The current packaging and documentation of the supplied batch remain decisive.
After verification of your business account, you can view the current price, stock and any volume discount. Request a quote for RADIESSE® 1.5 ml without lidocaine, quoting SKU RADI 0034 DSF2. Always compare the product name and variant on the quote with the original product packaging. This page does not replace the IFU, product training or medical assessment.
Check the product version, packaging, expiry date and batch/lot data on receipt.
RADIESSE® 1,5 ml without lidocaine for your clinic or practice? Review the product information, version and item code above. After activating your business account, log in to view the current price and availability and compose your order.
Read the background information and compare product names and packaging before preparing your business enquiry.
All product information and brands →Ask about quantities, delivery or regular orders of RADIESSE® 1,5 ml without lidocaine. Your product is prefilled in the contact form.